Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma

INTRODUCTION: Although the recommended optimal treatment of glioblastoma multiforme (GBM) is adjuvant chemoradiotherapy, trials in GBM have excluded patients older than 70 years. In this study, we aimed to assess overall survival (OS) and prognostic factors in elderly patients (≥ 70 years) with newl...

Descripción completa

Detalles Bibliográficos
Autores principales: Metcalfe, Evrim, Karaoglanoglu, Ozden, Akyazici, Emine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013689/
https://www.ncbi.nlm.nih.gov/pubmed/27647990
http://dx.doi.org/10.5114/wo.2016.61569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013689/
https://www.ncbi.nlm.nih.gov/pubmed/27647990
http://dx.doi.org/10.5114/wo.2016.61569

Ejemplares similares